Clinical Trial Update: Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating humoral and cellular immune responses to the Gardasil HPV vaccine in people with and without HIV, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Intraepithelial Neoplasia
• HIV Infection
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Human Papilloma Virus, Anal Dysplasia | Phase 2 | Status: RECRUITING